argenx SE (ARGX): Price and Financial Metrics

argenx SE (ARGX)

Today's Latest Price: $161.88 USD

1.76 (1.10%)

Updated Feb 19 6:55pm

Add ARGX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 339 in Biotech

See all "A" rated Strong Buy stocks

ARGX Stock Summary

  • The ratio of debt to operating expenses for Argenx Se is higher than it is for about merely 0.37% of US stocks.
  • ARGX's price/sales ratio is 224.89; that's higher than the P/S ratio of 98.7% of US stocks.
  • Over the past twelve months, ARGX has reported earnings growth of 191.72%, putting it ahead of 93.7% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Argenx Se, a group of peers worth examining would be FATE, MOR, RARX, DNLI, and ALPN.
  • ARGX's SEC filings can be seen here. And to visit Argenx Se's official web site, go to
ARGX Daily Price Range
ARGX 52-Week Price Range

ARGX Stock Price Chart More Charts

ARGX Price/Volume Stats

Current price $161.88 52-week high $169.50
Prev. close $160.12 52-week low $106.49
Day low $161.37 Volume 134,400
Day high $163.60 Avg. volume 143,133
50-day MA $156.12 Dividend yield N/A
200-day MA $137.05 Market Cap 6.17B

argenx SE (ARGX) Company Bio

arGEN-X N.V., a clinical-stage biopharmaceutical company, focuses on creating and developing therapeutic antibodies for the treatment of cancer and autoimmune diseases. The company was founded in 2008 and is based in Breda, Netherlands.

ARGX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ARGX Latest Social Stream

Loading social stream, please wait...

View Full ARGX Social Stream

ARGX Price Returns

1-mo 5.56%
3-mo 14.19%
6-mo 20.55%
1-year 29.11%
3-year N/A
5-year N/A
YTD 0.85%
2019 67.09%
2018 52.15%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6789 seconds.